Restoring SOD activity by the administration of Bacillus amyloliquefaciens SOD (BA SOD) to DSS-treated SOD-KO mice protected against colitis by inhibiting p38-MAPK/NF-kB signaling, which suggests the potential therapeutic use of BA SOD in colitis treatment [134]. This evidence concerns the gene SOD1 and colitis.